Using the envelope glycoprotein B (gB) crystal structure and digital prediction algorithm, the B- and T-cell antigenic determinants (epitopes) of human herpesvirus 1 (HHV-1), also known as herpes simplex virus 1 (HSV-1), were generated, and the method for their production in the form of recombinant proteins was proposed. First, the structure of the surface topological domain (ectodomain or spike) of gB with mapped epitopes was analyzed, and the most stable and immunogenic (due to their enrichment with B-and T-cell epitopes) subdomains were selected for the modeling of subunit vaccine prototypes using the AlphaFold2 (Google DeepMind, London, UK) artificial intelligence system. The proposed candidate vaccines included both small (about 100 amino acids) monomeric polypeptides, which were ideal for recombinant expression as fusion proteins, and a more complex polypeptide, which, due to its trimeric fold, looks like a miniature analog of the gB ectodomain. In this miniature analog, the ectodomain regions with the potential to interfere efficacious expression of soluble recombinant protein in Escherichia coli have been removed. The structural stability of the modeled proteins, confirmed by molecular dynamics simulation and host immune responses, predicted in silico, indicates the suitability of the two suggested polypeptides for generating subunit vaccines using recombinant DNA technology.
5 November 2023 in Biotechnology and Bioengineering
The model of the complex of the N-methyl–D-aspartate (NMDA) receptor with lipids of the postsynaptic membrane was obtained by molecular dynamics simulation. The time-dependent behavior of the components of the system is analyzed. The interactions of the NMDA receptor with lipids of the postsynaptic membrane are described. This complex can be used to study a system containing the NMDA receptor and lipids of the postsynaptic membrane at different concentrations.
1 January 2021 in Поверхность. Рентгеновские, синхротронные и нейтронные исследования.
Исследовано влияние замен аминокислотных остатков, формирующих границу между мономерами в димере HU-белка из Spiroplasma melliferum (HUSpm), на стабильность и конформационную динамику молекулы. Методом молекулярной динамики изучено поведение одиночных и множественных мутантов HUSpm. Моделирование осуществляли с использованием программного пакета GROMACS, в качестве силового поля использовали OPLS. Для каждого мутанта проведена полноатомная симуляция продолжительностью 50 нс. Полученные данные показали, что нарушения границы между мономерами в области альфа-спирального домена увеличивают подвижность молекулы в области ДНК-связывающего домена.
1 December 2024 in Applied Biochemistry and Microbiology
The production of target proteins in Escherichia coli cells can be greatly simplified if they are synthesized in a biologically active state as part of active inclusion bodies (AIBs), which can easily be isolated from cells by centrifugation. This is a new technology, so the question about the protective properties of AIBs specific for standard inclusion bodies still remains open. This work describes the synthesis of the recombinant protein L6KD-SUMO-[R34-GLP-1(7–37)], which forms AIB, in E. coli BL21(DE3) cells. This protein engineered from a novel, recently developed L6KD-SUMO platform incorporates a modified human glucagon-like peptide-1, R34-GLP-1(7–37), the active substance of Liraglutide-based drugs. It was shown that, the soluble protein His10-SUMO-[R34-GLP-1(7–37)] expressed by E. coli, retained the peptide intact only for 24 h, but the peptide integrity in the AIB composition was maintained over 70 h of cell cultivation. Thus, it is logical to assume that AIB formation has a protective effect on target compounds synthesized by the cell.
9 December 2025 in Applied Biochemistry and Microbiology
The synthesis of biologically active recombinant proteins and peptides in the form of active inclusion bodies (AIBs) significantly reduces production costs. Previously, we developed an original platform for the production of AIBs in Escherichia coli cells. It included the N-terminal self-aggregating peptide (SAP) L6KD fused to the SUMO (Smt3) protein of the yeast Saccharomyces cerevisiae, which is known for its chaperone activity. However, AIBs produced with this platform were sensitive to sonication and extrusion of cells with French press, leading to significant product loss during the cell lysate fractionation stage. To increase AIBs stability, we investigated modifications of the original SAP. we increased the hydrophobic core of SAPs and introduced additional intermolecular interactions between SAPs with disulfide or ionic bonds. The best results were obtained for peptides with an increased hydrophobic tail (L8KD), as well as for those containing sequences of 2‒4 cysteine residues directly at the N-terminus of the hydrophobic core of SAPs (C2L6KD, C3L6KD, C4L6KD). Integration of cysteine residues at a distance from the hydrophobic core of SAPs (C2G3L6KD, L6KDGSC2), as well as the formation of additional ionic bonds (KDL6KD, KDL8KD), did not lead to an increase in the stability of AIBs. The prposed SAP modifications did not significantly affect the synthesis of the target protein. Under sonication, the best-performing SAP variants increased AIB yield by 30‒40%. This improvement was also confirmed during cell disintegration by extrusion via French press.